We are live on ! Find out more
LA

Lynch & Associates Portfolio holdings

AUM $573M
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+21.74%
3 Year Est. Return
+62.9%
5 Year Est. Return
+80.86%
10 Year Est. Return
+253.75%
AUM
$175M
AUM Growth
+$5.59M
Cap. Flow
-$788K
Cap. Flow %
-0.45%
Top 10 Hldgs %
38.78%
Holding
97
New
1
Increased
53
Reduced
21
Closed
6

Sector Composition

Rank Sector Weight
1 Industrials 20.82%
2 Healthcare 16.16%
3 Miscellaneous 10.56%
4 Consumer Staples 10.53%
5 Energy 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPS icon
1
United Parcel Service
UPS
$89.7B
$15.5M 8.83%
150,607
-100
-0.1% -$10K
XOM icon
2
ExxonMobil
XOM
$642B
$8.97M 5.12%
89,090
+62
+0.1% +$6.25K
JNJ icon
3
Johnson & Johnson
JNJ
$640B
$8.64M 4.93%
82,597
+304
+0.4% +$30.7K
GE icon
4
GE Aerospace
GE
$357B
$5.83M 3.33%
46,260
+324
+0.7% +$41.2K
MSFT icon
5
Microsoft
MSFT
$3.79T
$5.47M 3.12%
131,142
+278
+0.2% +$11.3K
IJH icon
6
iShares Core S&P Mid-Cap ETF
IJH
$126B
$5.38M 3.07%
187,915
+5,480
+3% +$151K
PG icon
7
Procter & Gamble
PG
$334B
$4.73M 2.7%
60,227
+891
+2% +$71.8K
IBM icon
8
IBM
IBM
$223B
$4.71M 2.69%
27,156
-445
-2% -$80.1K
IVV icon
9
iShares Core S&P 500 ETF
IVV
$901B
$4.44M 2.53%
22,517
+170
+0.8% +$32.5K
WFC icon
10
Wells Fargo
WFC
$259B
$4.29M 2.45%
81,684
+789
+1% +$39.7K
PFE icon
11
Pfizer
PFE
$160B
$4.14M 2.37%
147,162
-1,946
-1% -$55.5K
INTC icon
12
Intel
INTC
$490B
$3.94M 2.25%
127,481
+10,253
+9% +$281K
DIS icon
13
Walt Disney
DIS
$186B
$3.65M 2.08%
42,550
-300
-0.7% -$24.5K
WBA
14
DELISTED
Walgreens Boots Alliance
WBA
$3.4M 1.94%
45,929
-200
-0.4% -$14K
VVC
15
DELISTED
Vectren Corporation
VVC
$3.33M 1.9%
78,338
-585
-0.7% -$23.4K
KO icon
16
Coca-Cola
KO
$387B
$3.32M 1.9%
78,449
-248
-0.3% -$10.1K
HON icon
17
Honeywell
HON
$69.2B
$3.32M 1.9%
39,758
CVX icon
18
Chevron
CVX
$393B
$3.19M 1.82%
24,398
+166
+0.7% +$20.7K
ABBV icon
19
AbbVie
ABBV
$454B
$3.09M 1.76%
54,747
+158
+0.3% +$8.29K
WMT icon
20
Walmart Inc
WMT
$819B
$3.05M 1.74%
121,995
+2,868
+2% +$73.7K
MRK icon
21
Merck
MRK
$364B
$3.04M 1.73%
55,000
-182
-0.3% -$9.93K
DD
22
DELISTED
Du Pont De Nemours E I
DD
$3.03M 1.73%
48,755
+211
+0.4% +$13.6K
EMR icon
23
Emerson Electric
EMR
$87.5B
$3.02M 1.72%
45,530
+2,911
+7% +$196K
USB icon
24
US Bancorp
USB
$97.7B
$2.77M 1.58%
63,947
-380
-0.6% -$15.9K
COP icon
25
ConocoPhillips
COP
$156B
$2.56M 1.46%
29,923
+734
+3% +$57.2K

Similar funds

Lynch & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Lynch & Associates held 97 positions worth $175M, up 3.3% from $170M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Lynch & Associates's Q2 2014 filing shows 1 new, 53 increased, 21 reduced and 6 closed positions. Its largest new stake was FS KKR Capital: 4,808 shares worth $205K. The largest sale was Arthur J. Gallagher & Co, an estimated $992K.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Lynch & Associates's largest Q2 2014 buy was FS KKR Capital: 4,808 shares worth $205K.
  • Lynch & Associates added most to Intel in Q2 2014, an estimated $281K increase.
  • Lynch & Associates's biggest Q2 2014 reduction was Bristol-Myers Squibb, cutting an estimated $664K.
  • Lynch & Associates fully exited Arthur J. Gallagher & Co in Q2 2014, selling an estimated $992K.
  • Lynch & Associates's ten largest holdings make up 39% of its $175M portfolio in Q2 2014.
  • Lynch & Associates opened 1 new position and closed 6 in Q2 2014.
  • Lynch & Associates's portfolio value rose 3.3% quarter-over-quarter to $175M.

Based on Lynch & Associates's 13F filing for Q2 2014, filed 15 Jul 2014.